
PD 198306
CAS No. 212631-61-3
PD 198306 ( —— )
产品货号. M27491 CAS No. 212631-61-3
PD 198306 是一种选择性 MAPK/ERK 激酶 (MEK) 抑制剂,具有抗痛觉过敏作用。 PD 198306 可降低链脲佐菌素 (Streptozocin) 诱导的活性 ERK1 水平的增加。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1912 | 有现货 |
![]() ![]() |
10MG | ¥2803 | 有现货 |
![]() ![]() |
25MG | ¥4706 | 有现货 |
![]() ![]() |
50MG | ¥6715 | 有现货 |
![]() ![]() |
100MG | ¥9315 | 有现货 |
![]() ![]() |
500MG | ¥18468 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PD 198306
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PD 198306 是一种选择性 MAPK/ERK 激酶 (MEK) 抑制剂,具有抗痛觉过敏作用。 PD 198306 可降低链脲佐菌素 (Streptozocin) 诱导的活性 ERK1 水平的增加。
-
产品描述PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.(In Vitro):PD 198306 (10?μM) reduces Tha-Crimson replication by 30% at 18?h and 50% at 36?h. PD 198306 (10? μM) significantly inhibits Tha-GFP replication by 25%.(In Vivo):In male Sprague Dawley rats bearing neuropathic pain, PD 198306 (1-30 μg/10 μL; i.t.) dose-dependently blocks static allodynia in both the chronic constriction injury and the streptozocin models.
-
体外实验PD198306 significantly inhibits Tha-GFP replication by 25% at 10?μM, after 36?h.PD198306 (5?μM) reduces Tha-Crimson replication significantly by 20% at 18?h but such a result could not be confirmed at 36?h. Cell Cycle Analysis Cell Line:Human induced pluripotent stem cells (iPSC) Concentration:10? μM Incubation Time:6? hours Result:Inhibited Tha-Crimson replication at 10?μM, reducing it by 30% at 18?h and 50% at 36?h.
-
体内实验Intrathecal administration of PD 198306 (1-30 μg per 10 μL) dose-dependently (1-30 μg) blocks static allodynia in both the streptozocin and the chronic constriction injury (CCI) models of neuropathic pain. Animal Model:Male Sprague Dawley rats (250-300 g) bearing neuropathic pain Dosage:1-30 μg per 10 μL and 3 mg per 100 μL (PD 198306 is suspended in cremophor:ethanol:water, 1 : 1 : 8.)Administration:Single doses of intrathecal (i.t.) or intraplantar (ipl) of PD 198306 (1-30 μg per 10 μL and 3 mg per 100 μL respectively Result:Intrathecal administration dose-dependently (1-30 μg) blocked static allodynia the streptozocin model of neuropathic pain. The minimum effective doses (MED) of 3 μg significantly blocked static allodynia 30 min after treatment. Both 10 μg and the highest dose used (30 μg) totally blocked the maintenance of static allodynia, for up to 1 h.
-
同义词——
-
通路MAPK/ERK Signaling
-
靶点MEK
-
受体Acidic mammalian chitinase (AMCase)|Bacterial|GH18 chitinase
-
研究领域——
-
适应症——
化学信息
-
CAS Number212631-61-3
-
分子量476.23
-
分子式C18H16F3IN2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(NOCC1CC1)C2=CC(F)=C(F)C(F)=C2NC3=CC=C(I)C=C3C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Schüttelkopf AW, et al. Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases. ACS Med Chem Lett. 2011;2(6):428-432. Published 2011 Mar 23.
产品手册




关联产品
-
RO-5126766
一种强效、一流的双重 Raf/MEK 抑制剂,对 C-Raf/MEK1 的 IC50 为 56 nM/160 nM。
-
MAP3K14-IN-173
一种新型有效的 MAP3K14 激酶抑制剂,IC50 为 1.8 nM(NIK 自磷酸化)。
-
Binimetinib
Binimetinib (MEK162、ARRY-162、ARRY-438162) 是一种有效的 MEK1/2 抑制剂,在无细胞测定中 IC50 为 12 nM。